Table 2. Univariate analysis and multivariate analysis in CHCC.
| Variables | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Age (≥60) | 3.03 (1.15–7.97) | 0.02 | 3.14 (1.16–8.49) | 0.02 | |
| Gender (male) | 0.90 (0.30–2.73) | 0.85 | |||
| Family cancer history (yes) | 0.85 (0.27–2.67) | 0.78 | |||
| Serum AFP level (≥400) | 1.61 (0.52–4.94) | 0.41 | |||
| Child-Pugh classification (B/A) | 2.94 (0.82–10.60) | 0.10 | 4.04 (0.94–17.30) | 0.06 | |
| Pathologic stage (III + IV/I + II) | 2.42 (0.80–7.36) | 0.12 | |||
| T stage (T3 + T4 + Tx/T1 + T2) | 2.89 (0.95–8.78) | 0.06 | 1.60 (0.44–5.85) | 0.48 | |
| N stage (N1 + N2 + Nx/N0) | 1.08 (0.35–3.38) | 0.89 | |||
| M stage (M1 + Mx/M0) | 2.20 (0.77–6.30) | 0.14 | |||
| Vessels in tumor (Micro + Macro/none) | 3.57 (1.44–8.86) | <0.01 | 3.51 (1.28–9.62) | 0.02 | |
| Recurrence (yes) | 1.36 (0.52–3.60) | 0.53 | |||
| SOX9 (high expression) | 0.55 (0.16–1.89) | 0.34 | |||
CHCC, cirrhotic hepatocellular carcinoma; HR, hazard ratio; CI, confidence interval; AFP, α-fetoprotein; Micro, microvessels; Macro, macrovessels; SOX9, Sex-Determining Region Y-Box 9.